0239.HK

Strong BuyFull HouseREMOVE

Pak Fah Yeow International Limited · Healthcare · Hong Kong · $98M · Avg Vol: $15K/d

Full House: Strong business, sensible price, market agrees. The rare full house.

100
StockRank
Get insider-trade alerts
Quality
79
Value
85
Momentum
72
P/E (TTM)
7.7x
peers 10.5x
ROE
13.8%
peers 5.7%
D/E
0.0x
peers 0.2x
Dividend %
2.7%
trailing yield
Director trades · 180d
None →
Buybacks · 180d
None →
AI CONVICTION THESIS

While the company has seen heavy insider activity, the thesis lacks a clear macro-driven catalyst or 'destination' business moat that aligns with our specific thematic requirements for a concentrated book.

Loading 1Y...
PRICE (1Y)+3.8%
0.300.310.320.330.33Aug 13Sep 3Sep 23
SMA 50SMA 200

Close
$0.3137
RSI (14)
25.0
52W High
$0.3481
From 52W High
0.9%

SCORE BREAKDOWN

Quality
79
ROIC
13.4%79.1
ROE
13.8%79.7
GP/Assets
23.1%51.0
Op. Margin
55.7%98.8
FCF/Assets
13.6%92.0
Piotroski
376.5
Int. Cover
50.0x89.3
D/E Ratio
0.01x87.4
Current Ratio
7.23x81.5
Value
85
P/E (TTM)
7.7x92.8
EV/EBITDA
3.0x97.2
P/FCF
6.8x89.9
P/B
1.0x83.1
P/S
3.5x51.0
Div Yield
2.7%64.2
Momentum
72
52W High %
90%84.7
RS 6M
11%73.0
SMA 50/200
1.04x65.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
19%54.7

FUNDAMENTALS

Market Cap
$98M
P/E (Forward)
—
Gross Margin
86.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 0239.HK are excluded.

TickerCompanyMkt CapStockRankSignal
0239.HKPak Fah Yeow International Limited(you)$98M100Strong Buy
8049.HKJilin Province Huinan Changlong Bio-pharmacy Company Limited$169M100Strong Buy
2348.HKDawnrays Pharmaceutical (Holdings) Limited$188M99Strong Buy
0950.HKLee's Pharmaceutical Holdings Limited$91M85Strong Buy
2161.HKJBM (Healthcare) Limited$172M89Strong Buy
3839.HKCPBIO Holding Company Limited$249M95Strong Buy
2633.HKJacobson Pharma Corporation Limited$242M92Strong Buy
3613.HKBeijing Tong Ren Tang Chinese Medicine Company Limited$582M92Strong Buy
0897.HKWai Yuen Tong Medicine Holdings Limited$52M62Hold
2005.HKSSY Group Limited$1.0B86Strong Buy

Peer medians: ROE 5.7% · P/E 10.5x · Gross margin 42.1%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Pak Fah Yeow International Limited (0239.HK): Stock Score Summary

Pak Fah Yeow International Limited (0239.HK) has a MoatMap StockRank of 100/100 based on Quality (79/100), Value (85/100), and Momentum (72/100) factor scores. The current signal is STRONG BUY. While the company has seen heavy insider activity, the thesis lacks a clear macro-driven catalyst or 'destination' business moat that aligns with our specific thematic requirements for a concentrated book.

Key Financial Metrics

Price$0.31
Market Cap$98M
P/E (TTM)7.69
Price/Book1.04
Return on Equity13.8%
Return on Invested Capital13.4%
Debt/Equity0.01x
Gross Margin86.8%
Operating Margin55.7%
Revenue Growth6.8%
Dividend Yield2.7%
Free Cash Flow$14M

Pak Fah Yeow International Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Hong Kong).

Frequently Asked Questions

What is Pak Fah Yeow International Limited’s (0239.HK) StockRank?
MoatMap’s StockRank for Pak Fah Yeow International Limited (0239.HK) is 100/100, with a Strong Buy signal. It is a composite of Quality (79), Value (85), and Momentum (72) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Pak Fah Yeow International Limited have an economic moat?
Pak Fah Yeow International Limited (0239.HK) has a Quality factor score of 79/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Pak Fah Yeow International Limited a buy, hold, or sell?
MoatMap’s current signal for Pak Fah Yeow International Limited (0239.HK) is Strong Buy, based on a StockRank of 100/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Pak Fah Yeow International Limited in?
Pak Fah Yeow International Limited (0239.HK) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Hong Kong).
Browse all ranked stocks0239.HK deep dive reportAI ChampionsHow we score stocksSense-check another stock